<DOC>
	<DOCNO>NCT00262782</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , fludarabine , work different way stop growth cancer cell , either kill cell stop dividing . Sometimes , cancer may need treatment progress . In case , observation may sufficient . It yet know whether fludarabine effective observation treat chronic lymphocytic leukemia . PURPOSE : This randomized phase III trial study fludarabine see well work compare observation treat patient stage 0 , stage I , stage II B-cell chronic lymphocytic leukemia .</brief_summary>
	<brief_title>Fludarabine Observation Treating Patients With Stage 0 , Stage I , Stage II Chronic Lymphocytic Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - Identify prognostic factor predict short survival patient stage 0-II B-cell chronic lymphocytic leukemia treat fludarabine observation . OUTLINE : This randomize study . Patients stratify accord risk ( high risk vs low risk ) . Patients low-risk group undergo observation . Patients high-risk group randomize 1 2 treatment arm . - Arm I : Patients receive fludarabine . - Arm II : Patients undergo observation . PROJECTED ACCRUAL : A total 880 patient accrue study .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Confirmed diagnosis Bcell chronic lymphocytic leukemia Rai stage 0II ( Binet stage A ) disease Meets 1 follow criterion : Highrisk disease , define follow : Serum thymidine kinase level &gt; 7.0 U/L Elevated Î²2microglobulin level Presence nonnodular bone marrow infiltration Short lymphocyte double time Lowrisk disease Meets none criterion ( list ) highrisk disease PATIENT CHARACTERISTICS : Performance status Not specify Life expectancy More 6 month Hematopoietic No autoimmune hemolytic anemia No thrombocytopenia Hepatic Not specify Renal Not specify Other No severe organ dysfunction No prior concurrent malignancy PRIOR CONCURRENT THERAPY : Chemotherapy No prior chemotherapy No concurrent chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>B-cell chronic lymphocytic leukemia</keyword>
	<keyword>stage 0 chronic lymphocytic leukemia</keyword>
	<keyword>stage I chronic lymphocytic leukemia</keyword>
	<keyword>stage II chronic lymphocytic leukemia</keyword>
</DOC>